Plain-English translation of NCT06982976 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing photodynamic therapy—a treatment that uses a special red light combined with a medication to treat precancerous changes in your cervix or vagina. Doctors want to learn how well and how safely this treatment works in real-world settings, for women who have been diagnosed with these types of lesions.
Precancerous changes in the cervix and vagina need treatment to prevent them from becoming cancer. This trial exists to see whether this light-based treatment could be an effective option for women who have these lesions, giving patients and doctors more choices for care.
You likely qualify if…
You likely don't qualify if…
If you join, you will choose to receive the photodynamic therapy treatment. The procedure involves applying a light-sensitizing medication and then exposing the affected area to red light. You will need to complete colposcopy imaging before treatment so doctors can carefully map your lesion, and you'll be monitored to see how well the treatment works and to watch for any side effects.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
China
Sponsor
Peking University Third Hospital
Enrollment target
~250 participants
Started
February 2025
Primary completion
December 2028
Age range
18 Years – 65 Years
Sex
Female only
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Qin Han
Peking University Third Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.